NeuroOne Medical Technologies Corporation
NMTC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,741 | $1,696 | $1,387 | $3,274 |
| % Growth | 61.6% | 22.3% | -57.7% | – |
| Cost of Goods Sold | $1,212 | $781 | $615 | $1,347 |
| Gross Profit | $1,529 | $915 | $771 | $1,927 |
| % Margin | 55.8% | 53.9% | 55.6% | 58.9% |
| R&D Expenses | $1,118 | $1,182 | $1,511 | $1,172 |
| G&A Expenses | $0 | $1,574 | $0 | $2,005 |
| SG&A Expenses | $1,782 | $1,619 | $1,940 | $2,043 |
| Sales & Mktg Exp. | $0 | $45 | $0 | $39 |
| Other Operating Expenses | $0 | $0 | $0 | -$3,000 |
| Operating Expenses | $2,900 | $2,801 | $3,451 | $216 |
| Operating Income | -$1,371 | -$1,887 | -$2,680 | $1,711 |
| % Margin | -50% | -111.2% | -193.3% | 52.3% |
| Other Income/Exp. Net | -$248 | $386 | $409 | $74 |
| Pre-Tax Income | -$1,619 | -$1,501 | -$2,271 | $1,785 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,619 | -$1,501 | -$2,271 | $1,785 |
| % Margin | -59.1% | -88.5% | -163.8% | 54.5% |
| EPS | -0.044 | -0.031 | -0.073 | 0.058 |
| % Growth | -42.4% | 57.7% | -226.1% | – |
| EPS Diluted | -0.044 | -0.031 | -0.073 | 0.058 |
| Weighted Avg Shares Out | 40,153 | 48,605 | 31,112 | 30,838 |
| Weighted Avg Shares Out Dil | 40,153 | 48,605 | 31,112 | 30,880 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | -$334 | $9 | $0 | $325 |
| Depreciation & Amortization | $64 | $67 | $66 | $65 |
| EBITDA | -$1,555 | -$1,425 | -$2,205 | $2,175 |
| % Margin | -56.7% | -84% | -159% | 66.4% |